Uşaqlıq cismi neoplazmlarının histokimyəvi tədqiqatı

H. K. Muradov; İ. O. Əliyeva; G. H. Sadıxova; T. A. İbrahimova; F. H. İbrahimova

doi:10.28942/jtcem.v1i4.68

Vol. 1 No. 4 (2018)

Case Reports

Histochemical investigation in uterine's body neoplasm

Published: November 16, 2018

DOI: https://doi.org/10.28942/jtcem.v1i4.68

Abstract

The histochemical analysis of various localizational neolasia has revealed that the histochemical features of the tumor have increased and decreased, depending on the histogenesis of tumors, the degree of differentiation and clinical course. Histochemical heterogeneity of tumors is very important in diagnosis, histogenesis diagnosis and prediction of tumors in practical oncology. According to literature data, most adenocarcinomas, mostly adenocarcinomas in prostate gland, react positively to acid phosphatase.

References

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J. Clin. 2009;59:225–249.

Hendrickson MR, Kempson RL. Histology for pathologists. Philadelphia: Lippincott-Raven Publishers:; 1997. Normal histology of the uterus and fallopian tubes.

Jacques SM, Qureshi F, Ramirez NC, Malviya VK, Lawrence WD. Tumors of the uterine isthmus: Clinicopathologic features and immunohistochemical characterization of p53 expression and hormone receptors. Int. J. Gynecol. Pathol. 1997;13:33–44.

Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 1983;15:10–17.

Hachisuga T, Fukuda K, Iwasaka T, Hirakawa T, Kawarabashi T, Tsuneyoshi M. Endometrioid adenocarcinomas of the uterine corpus in women younger than 50 years of age can be divided into two distinct clinical and pathologic entities based on anatomic location. Cancer. 2001;92:2578–2584.

Watanabe Y, Nakajima H, Nozaki K, Ueda H, Obata K, Hoshiai H, Noda K. Clinicopathologic and immunohistochemical features and microsatellite status of endometrial cancer of the uterine isthmus. Int. J. Gynecol. Pathol. 2001;20:368–373.

Lax S, Pizer E, Ronnett B, Kurman R. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum. Pathol. 1998;29:551–558.

Lax S, Kendall B, Tashiro H, Slebos R, Ellenson L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma. Cancer. 2000;88:814–824.

Jiko K, Tsuda H, Sato S, Hirohashi S. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int. J. Cancer. 1994;59:601–606.

Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial carcinoma patients. Cancer Res. 2006;66:7810–7817.

Histochemical investigation in uterine's body neoplasm

Abstract

References

Keywords

Most read articles by the same author(s)